Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03630640
Title Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation (NIVOLEP)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications

hepatocellular carcinoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.